5J3 Stock Overview
SciBase Holding AB (publ), a medical technology company, develops and sells instruments for the detection of skin cancer and other skin conditions in Europe and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
SciBase Holding AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.016 |
| 52 Week High | kr0.14 |
| 52 Week Low | kr0.001 |
| Beta | 1.49 |
| 1 Month Change | 43.12% |
| 3 Month Change | -70.73% |
| 1 Year Change | -88.48% |
| 3 Year Change | -98.21% |
| 5 Year Change | n/a |
| Change since IPO | -95.03% |
Recent News & Updates
Recent updates
Shareholder Returns
| 5J3 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 11.4% | 2.1% | 0.5% |
| 1Y | -88.5% | -8.4% | 1.3% |
Return vs Industry: 5J3 underperformed the German Medical Equipment industry which returned -7.7% over the past year.
Return vs Market: 5J3 underperformed the German Market which returned 2.3% over the past year.
Price Volatility
| 5J3 volatility | |
|---|---|
| 5J3 Average Weekly Movement | 340.1% |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 5J3's share price has been volatile over the past 3 months.
Volatility Over Time: 5J3's weekly volatility has increased from 171% to 340% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 27 | Pia Renaudin | www.scibase.com |
SciBase Holding AB (publ), a medical technology company, develops and sells instruments for the detection of skin cancer and other skin conditions in Europe and internationally. The company operates through Skin Cancer and Skin Barrier Assessment segments. Its products include Nevisense and Nevisense Go point of care platforms that addresses in the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment.
SciBase Holding AB (publ) Fundamentals Summary
| 5J3 fundamental statistics | |
|---|---|
| Market cap | €3.88m |
| Earnings (TTM) | -€4.76m |
| Revenue (TTM) | €1.99m |
1.9x
P/S Ratio-0.8x
P/E RatioIs 5J3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 5J3 income statement (TTM) | |
|---|---|
| Revenue | kr23.25m |
| Cost of Revenue | kr7.21m |
| Gross Profit | kr16.04m |
| Other Expenses | kr71.62m |
| Earnings | -kr55.58m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 31, 2024
| Earnings per share (EPS) | -0.46 |
| Gross Margin | 68.99% |
| Net Profit Margin | -239.13% |
| Debt/Equity Ratio | 0% |
How did 5J3 perform over the long term?
See historical performance and comparison